Sandoz receives European Commission approval for biosimilar filgrastim

Links shared publicly online about this topic.

  • 2,261
    total visits

Sandoz receives European Commission approval for biosimilar filgrastim

novartis.com —

Sandoz receives European Commission approval for biosimilar filgrastim

View full resource at novartis.com

Tags: Neutropenia Medication, Neupogen

  • Share

Most Recently Shared on February 13, 2009 at 12:42 pm By:

eyeonfda eyeonfda

Sandoz receives European Commission approval for its 3rd biosimilar - filgrastim - http://is.gd/jpAW

3 years ago...

Reply

Retweet

Favorite

Also Shared By:

Novartis Novartis

Advertisement